Categorization of eosinophilic chronic rhinosinusitis

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 12, Issue 3, 2004, Pages 237-242

  Ferguson, Berrylin J ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Allergic fungal sinusitis; Categorization of chronic sinusitis; Chronic rhinosinusitis; Eosinophilic rhinosinusitis; Nasal polyps; Superantigen

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; CYTOKINE; IMMUNOGLOBULIN E;

CLINICAL TRIAL; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; EOSINOPHILIA; EOSINOPHILIC CHRONIC RHINOSINUSITIS; HISTOPATHOLOGY; HUMAN; IMMUNOMODULATION; INFLAMMATION; META ANALYSIS; MYCOSIS; NOSE POLYP; PRIORITY JOURNAL; REVIEW; RHINOSINUSITIS; SYSTEMATIC REVIEW; TH2 CELL; TREATMENT OUTCOME;

ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPIRIN; CHILD; CHRONIC DISEASE; EOSINOPHILIA; EOSINOPHILS; HUMANS; IMMUNOGLOBULIN E; LEUKOCYTE COUNT; MYCOSES; RHINITIS, ALLERGIC, PERENNIAL; RISK FACTORS; SINUSITIS; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 2542433496     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000124938.46948.c7     Document Type: Review

References (25)

1. Newman U, Platts-Mills TA, Phillips CD, et al.: Chronic sinusitis: relationship of computed tomographic findings to allergy, asthma, and eosinophilia. JAMA 1994, 271:363-367.
2. Hoover GE, Newman LJ, Platts-Mills TA, et al.: Chronic sinusitis: risk factors for extensive disease. J Allergy Clin Immunol 1997, 100:185-191.
3. Szucs E, Ravandi A, Goossens A, et al.: Eosinophilia in the ethmoid mucosa and its relationship to the severity of inflammation in chronic rhinosinusitis. Am J Rhinol 2002, 16:131-134.
4. Baroody FM, Hughes CA, McDowell P, et al.: Eosinophilia in chronic childhood sinusitis. Arch Otolaryngol Head Neck Surg 1995, 121:1396-1402.
5. Sobol SE, Fukakusa M, Christodoulopoulos P, et al.: Inflammation and remodeling of the sinus mucosa in children and adults with chronic sinusitis. Laryngoscope 2003, 113:410-414. This small study of seven children, seven adults with CRS, and six control subjects found evidence of irreversible change in adults characterized by the deposition of collagen fibers, which exceeded that seen in children.
6. Zadeh MH, Banthia V, Anand VK, et al.: Significance of eosinophilia in chronic rhinosinusitis. Am J Rhinol 2002, 16:313-317. This huge retrospective study finds a surprisingly low number of patients with peripheral eosinophilia compared with other series. Nevertheless, it dramatically illustrates the poorer postoperative result achieved in patients with serum eosinophilia compared with those without serum eosinophilia. The authors advocate that these patients be counseled preoperatively for the likelihood of continued symptoms postoperatively and need for revisional surgeries.
7. Bochner BS: Verdict in the case of therapies versus eosinophils: the jury is still out. J Allergy Clin Immunol 2004, 113:3-9. This is a comprehensive yet concise review of the eosinophil by a leader in the field, particularly as it relates to asthma. The figure of almost a hundred examples of surface molecules expressed by the human eosinophil in this article is worthy of review for anyone desiring more information about the eosinophil.
8. Alam R, Busse WW: The eosinophil-quo vadis? J Allergy Clin Immunol 2004, 113:38-42. This short and entertaining editorial frames the question for the role and contribution of eosinophils in different disease states and outlines the putative role as well as the complexities involved in understanding this role.
9. Leckie MJ, Brinke A, Khan J, et al.: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000, 356:2144-2148.
10. Bernstein JM, Ballow M, Schlievert PM, et al.: A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol 2003, 17:321-326. This is the first study to show clonal expansion of the variable β region of the T-cell receptors unregulated by SE or superantigen. The author makes the case for superantigens from Staphylococcus as a cause for eosinophilic nasal polyposis.
11. Bachert C, Gevaert P, Holtappels G, et al.: Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001, 107:607-614.
12. Schubert MS: A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis, and related disorders. Ann Allergy Asthma Immunol 2001, 87:181-188.
13. Marple BF: Allergic fungal rhinosinusitis: current theories and management strategies. Laryngoscope 2001, 111:1006-1019.
14. Manning S, Mabry R, Schaefer S, et al.: Evidence of IgE-mediated hypersensitivity in allergic fungal sinusitis. Laryngoscope 1993, 103:717-721.
15. Schubert MS: Antileukotriene therapy for allergic fungal sinusitis. J Allergy Clin Immunol 2001, 108:466-467.
16. Stevens DA, Schwartz HJ, Lee JY, et al.: A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000, 342:756-762.
17. Bassichis BA, Marple BF, Mabry RL, et al.: Use of immunotherapy and previously treated patients with allergic fungal sinusitis. Otolaryngol Head Neck Surg 2001, 125:487-490.
18. Ponikau JU, Sherris DA, Kern EB, et al.: The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999, 515:18-21.
19. Braun H, Buzina W, Freudenschuss K, et al.: Eosinophilic fungal rhinosinusitis: a common disorder in Europe? Laryngoscope 2003, 113:264-269.
20. Lebowitz RA, Waltzman MN, Jacobs J, et al.: Isolation of fungi by standard laboratory methods in patients with chronic rhinosinusitis. Laryngoscope 2002, 112:2189-2191.
21. Ferguson BJ: Eosinophilic mucin rhinosinusitis-a distinctive clinicopathological entity. Laryngoscope 2000, 110:799-813.
22. Ponikau J, Sherris D, Kita H, et al.: Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2002, 110:862-866. Although the authors report impressive success rates with topical antifungal in patients with CRS, their failure to include a control group renders the study inconclusive with regard to any efficacy from the antifungal. This criticism is elaborated on in a letter to the editor regarding this paper [23].
23. Ferguson BJ: Antifungal nasal washes for chronic rhinosinusitis: what's therapeutic-the wash or the antifungal [letter]? J Allergy Clin Immunol 2003, 111:1137-1138.
24. Szczeklik A, Stevenson DD: Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003, 111:913-921. This review article comprehensively reviews the clinical as well as the pathophysiologic basis of aspirin-exacerbated ECRS. Don Stevenson pioneered aspirin desensitization almost 20 years ago.
25. Sousa AR, Parikh A, Scadding G, et al.: Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002, 347:1493-1499. The elegant histochemistry nicely demonstrates the elevation of cystinyl leukotriene receptors as well as a downregulation of these receptors with topical aspirin desensitization in patients with aspirin-exacerbated ECRS, not seen in the patient's nonaspirin-sensitive counterparts. The authors conclude that the elevated expression of CysLT1 receptor in aspirin-exacerbated ECRS is probably fundamental to the pathogenesis of aspirin sensitivity and to the mechanism of aspirin desensitization.